BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ng SP, Herman JM. Stereotactic Radiotherapy and Particle Therapy for Pancreatic Cancer. Cancers (Basel) 2018;10:E75. [PMID: 29547526 DOI: 10.3390/cancers10030075] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Wu J, Palta M, Zhang Y, Sheng Y, Zhang J, Wang C. A Collimator Setting Optimization Algorithm for Dual-Arc Volumetric Modulated Arc Therapy in Pancreas Stereotactic Body Radiation Therapy. Technol Cancer Res Treat 2019;18:1533033819870767. [PMID: 31426721 DOI: 10.1177/1533033819870767] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wang C, Zhu X, Hong JC, Zheng D. Artificial Intelligence in Radiotherapy Treatment Planning: Present and Future. Technol Cancer Res Treat. 2019;18:1533033819873922. [PMID: 31495281 DOI: 10.1177/1533033819873922] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 34.0] [Reference Citation Analysis]
3 Liu Y, Lei Y, Wang T, Fu Y, Tang X, Curran WJ, Liu T, Patel P, Yang X. CBCT-based synthetic CT generation using deep-attention cycleGAN for pancreatic adaptive radiotherapy. Med Phys 2020;47:2472-83. [PMID: 32141618 DOI: 10.1002/mp.14121] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 20.0] [Reference Citation Analysis]
4 Saccomandi P, Lapergola A, Longo F, Schena E, Quero G. Thermal ablation of pancreatic cancer: A systematic literature review of clinical practice and pre-clinical studies. Int J Hyperthermia. 2018;35:398-418. [PMID: 30428728 DOI: 10.1080/02656736.2018.1506165] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 9.3] [Reference Citation Analysis]
5 Aghevlian S, Cai Z, Lu Y, Hedley DW, Winnik MA, Reilly RM. Radioimmunotherapy of PANC-1 Human Pancreatic Cancer Xenografts in NRG Mice with Panitumumab Modified with Metal-Chelating Polymers Complexed to 177Lu. Mol Pharm 2019;16:768-78. [PMID: 30589553 DOI: 10.1021/acs.molpharmaceut.8b01040] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
6 Lekka K, Tzitzi E, Giakoustidis A, Papadopoulos V, Giakoustidis D. Contemporary management of borderline resectable pancreatic ductal adenocarcinoma. Ann Hepatobiliary Pancreat Surg 2019;23:97-108. [PMID: 31225409 DOI: 10.14701/ahbps.2019.23.2.97] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]